Cargando…
High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome
BACKGROUND: Polycystic ovarian syndrome (PCOS) is a common disease among women in fertility ages and cause severe insulin resistance. Hyperhomocysteinaemia is said to be among the features of PCOS that could influence its outcome. OBJECTIVE: This study aimed to investigate whether hyperhomocysteinae...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research and Clinical Center for Infertility
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575758/ https://www.ncbi.nlm.nih.gov/pubmed/26396568 |
_version_ | 1782390813880221696 |
---|---|
author | Hemati, Tayebe Moghadami-Tabrizi, Nasrin Davari-Tanha, Fateme Salmanian, Bahram Javadian, Pouya |
author_facet | Hemati, Tayebe Moghadami-Tabrizi, Nasrin Davari-Tanha, Fateme Salmanian, Bahram Javadian, Pouya |
author_sort | Hemati, Tayebe |
collection | PubMed |
description | BACKGROUND: Polycystic ovarian syndrome (PCOS) is a common disease among women in fertility ages and cause severe insulin resistance. Hyperhomocysteinaemia is said to be among the features of PCOS that could influence its outcome. OBJECTIVE: This study aimed to investigate whether hyperhomocysteinaemia exists in PCOS and if it is related to insulin resistance in the affected patients. MATERIALS AND METHODS: This prospective study was carried out in a university based fertility clinic. Sixty four PCOS patients and 50 normo ovulatory controls were reviewed for fasting glucose, insulin, homocysteine, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) plasma levels in the blood sample of the 3(rd) day of their menstrual cycle. Insulin resistance was determined with the fasting glucose (mmol/L) to insulin (mIU/L) ratio and HOMA-IR (Homeostasis model assessment-Insulin resistance). Independent-samples T-test and linear regression test were utilized to analyze the obtained data. RESULTS: Homocysteine levels compared between PCOS patients and control group showed a significant difference. PCOS group was divided into insulin resistant (IR) (LogHOMA-IR≥0.57) and non insulin resistant (NIR) patients. The IR group had significantly higher homocysteine (p-value=0.02), fasting insulin and glucose levels (p-value<0.001) rather than NIR group. CONCLUSION: PCOS patients have a leaning toward hyperhomocysteinaemia and insulin resistance. Insulin resistant patients are found to have higher homocysteine level. |
format | Online Article Text |
id | pubmed-4575758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Research and Clinical Center for Infertility |
record_format | MEDLINE/PubMed |
spelling | pubmed-45757582015-09-22 High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome Hemati, Tayebe Moghadami-Tabrizi, Nasrin Davari-Tanha, Fateme Salmanian, Bahram Javadian, Pouya Iran J Reprod Med Original Article BACKGROUND: Polycystic ovarian syndrome (PCOS) is a common disease among women in fertility ages and cause severe insulin resistance. Hyperhomocysteinaemia is said to be among the features of PCOS that could influence its outcome. OBJECTIVE: This study aimed to investigate whether hyperhomocysteinaemia exists in PCOS and if it is related to insulin resistance in the affected patients. MATERIALS AND METHODS: This prospective study was carried out in a university based fertility clinic. Sixty four PCOS patients and 50 normo ovulatory controls were reviewed for fasting glucose, insulin, homocysteine, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) plasma levels in the blood sample of the 3(rd) day of their menstrual cycle. Insulin resistance was determined with the fasting glucose (mmol/L) to insulin (mIU/L) ratio and HOMA-IR (Homeostasis model assessment-Insulin resistance). Independent-samples T-test and linear regression test were utilized to analyze the obtained data. RESULTS: Homocysteine levels compared between PCOS patients and control group showed a significant difference. PCOS group was divided into insulin resistant (IR) (LogHOMA-IR≥0.57) and non insulin resistant (NIR) patients. The IR group had significantly higher homocysteine (p-value=0.02), fasting insulin and glucose levels (p-value<0.001) rather than NIR group. CONCLUSION: PCOS patients have a leaning toward hyperhomocysteinaemia and insulin resistance. Insulin resistant patients are found to have higher homocysteine level. Research and Clinical Center for Infertility 2011 /pmc/articles/PMC4575758/ /pubmed/26396568 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Hemati, Tayebe Moghadami-Tabrizi, Nasrin Davari-Tanha, Fateme Salmanian, Bahram Javadian, Pouya High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome |
title | High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome |
title_full | High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome |
title_fullStr | High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome |
title_full_unstemmed | High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome |
title_short | High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome |
title_sort | high plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575758/ https://www.ncbi.nlm.nih.gov/pubmed/26396568 |
work_keys_str_mv | AT hematitayebe highplasmahomocysteineandinsulinresistanceinpatientswithpolycysticovariansyndrome AT moghadamitabrizinasrin highplasmahomocysteineandinsulinresistanceinpatientswithpolycysticovariansyndrome AT davaritanhafateme highplasmahomocysteineandinsulinresistanceinpatientswithpolycysticovariansyndrome AT salmanianbahram highplasmahomocysteineandinsulinresistanceinpatientswithpolycysticovariansyndrome AT javadianpouya highplasmahomocysteineandinsulinresistanceinpatientswithpolycysticovariansyndrome |